After Five Years of Successful Experience Internationally, Biocon Biologics’ Hulio® Biosimilar to Humira®, Now Available in the United States

Hulio bAdalimumab
  • Posted by: Biocon Biologics

Biocon Group concluded the month-long sustainability initiatives commemorating ‘World Environment Day’ initiated with ‘Nature Positive’ Campaign

  • Posted by: Biocon Biologics

Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31%

  • Posted by: Biocon Biologics

Biocon Biologics’ New mAbs Facility Receives EU GMP Certification for bBevacizumab

  • Posted by: Biocon Biologics

Serum & Biocon Biologics Agree to Restructure Equity Investment

  • Posted by: Biocon Biologics

Biocon Awarded a Silver Medal by EcoVadis for its Sustainability Accomplishments

  • Posted by: Biocon Biologics

Biocon Biologics Wins the ‘ABEA : Bioprocessing Excellence in South Asia’ Award

  • Posted by: Biocon Biologics

Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%

  • Posted by: Biocon Biologics

Biocon Biologics Recognized as a Company with Great Managers; Two Managers conferred with individual ‘Great Managers Award 2022’

  • Posted by: Biocon Biologics

Shreehas Tambe Appointed as Managing Director & CEO of Biocon Biologics Limited

  • Posted by: Biocon Biologics
Share